ArticleIranian journal of basic medical sciences2020
Inhibition of miR-22 enhanced the efficacy of icotinib plus pemetrexed in a rat model of non-small cell lung cancer.
Jing Zhang et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.